Marzia Cavalli

Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

Sara Galimberti, Stefano Luminari, Elena Ciabatti et al. · Clinical Cancer Research · 2014 · 112 citations · Full text

Hematological Malignancy, Pcr Status, Mrd Negativity +13

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Sabina Chiaretti, Monica Messina, Irene Della Starza et al. · Haematologica · 2020 · 78 citations · Full text

Poor Outcome, Mixed-phenotype Acute Leukemia, Immunology +16

Comparative analysis between RQ‐PCR and digital‐droplet‐PCR of immunoglobulin/T‐cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia

Irene Della Starza, Vittorio Nunes, Marzia Cavalli et al. · British Journal of Haematology · 2016 · 69 citations · Full text

Comparative analysis between <scp>RQ</scp>‐<scp>PCR</scp> and digital droplet <scp>PCR</scp> of <i><scp>BCL</scp>2/<scp>IGH</scp></i> gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma

Marzia Cavalli, Lucia Anna De Novi, Irene Della Starza et al. · British Journal of Haematology · 2017 · 44 citations · Full text

Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase <scp>II</scp> pediatric‐like <scp>GIMEMA LAL</scp>‐1308 trial

Anna Maria Testi, Martina Canichella, Antonella Vitale et al. · American Journal of Hematology · 2020 · 35 citations · Full text